Related scientific articles (all)

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

Authors : Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Láng I, Gómez HL, Tondini C, Ciruelos E, Burstein HJ, Bonnefoi HR, Bellet M, Martino S, Geyer CE Jr, Goetz MP, Stearns V, Pinotti G, Puglisi F, Spazzapan S, Climent MA, Pavesi L, Ruhstaller T, Davidson NE, Coleman R, Debled M, Buchholz S, Ingle JN, Winer EP, Maibach R, Rabaglio-Poretti M, Ruepp B, Di Leo A, Coates AS, Gelber Rd, Goldhirsch A, Regan MM, + collaborators (among others :, Piccart-Gebhart M
Year : 2018
Journal : N Engl J Med
Volume : 379
Pages : 122-137

Supportive care in the era of immunotherapies for advanced non-small-cell lung cancer.

Authors : Awada G, Klastersky J
Year : 2018
Journal : Curr Opin Oncol
Volume : 30(2)
Pages : 98-104

Reply to ESMO-MCBS v1.1: Statistical and Patient Relevant Shortcomings" by R. Emprechtinger et al."

Authors : Cherny NI, Dafni U, Piccart-Gebhart M, Latino NJ, Douillard JY, Bogaerts J, Karlis D, Zygoura P, Pentheroudakis G, Tabernero J, Zielinski C, de Vries EGE
Year : 2018
Journal : Ann Oncol
Volume : 29(5)
Pages : 1335-1338

A rare case of hepatotoxicity in geriatrics.

Authors : El Kahi C, Martinet V, Praet JP, Pepersack T
Year : 2018
Journal : Rev Med Brux
Volume : 39
Pages : 164-165

Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer.

Authors : Basaran G, Twelves C, Diéras V, Cortés J, Awada A
Year : 2018
Journal : Cancer Treat Rev
Volume : 63
Pages : 144-155

Long-Term Clinical Outcome and Survivorship Issues of High Grade Bone Sarcomas

Authors : Closset C, Ameye L, Gebhart M, de Saint-Aubain de Somerhausen N, Beauvois S, Awada A, Piccart-Gebhart M, Gil T
Year : 2018
Journal : Int J cancer and oncology
Volume : 5(1)
Pages : 26-34

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.

Authors : Bidard FC, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, Naume B, Horiguchi J, Gisbert-Criado R, Sleijfer S, Toi M, Garcia-Saenz JA, Hartkopf A, Generali D, Rothé F, Smerage J, Muinelo-Romay L, Stebbing J, Viens P, Magbanua MJM, Hall CS, Engebraaten O, Takata D, Vidal-Martínez J, Onstenk W, Fujisawa N, Diaz-Rubio E, Taran FA, Cappelletti MR, Ignatiadis M, Proudhon C, Wolf DM, Bauldry JB, Borgen E, Nagaoka R, Carañana V, Kraan J, Maestro M, Brucker SY, Weber K, Reyal F, Amara D, Karhade MG, Mathiesen RR, Tokiniwa H, Llombart-Cussac A, Meddis A, Blanche P, dHollander K, Pantel K
Year : 2018
Journal : J Natl Cancer Inst
Volume : 110(6)
Pages : 560-567

White blood cell counts in a geriatric hospitalized population: A poor diagnostic marker of infection.

Authors : Compté N, Dumont L, Bron D, De Breucker S, Praet JP, Bautmans I, Pepersack T
Year : 2018
Journal : Exp Gerontol
Volume : 114
Pages : 87-92

Retroperitoneal mixed malignant mullerian tumor : exceptional localisation and prognosis.

Authors : El Hachem G, Jungels C, Larsimont D, Awada A
Year : 2018
Journal : Rev Med Brux
Volume : 39
Pages : 146-149

Frailty in old Age is associated with altered cytokine production in response to TLR ligation. in : Fulop T, Franceschi C, Hirokawa K, Pawelec G (eds)- Handbook of Immunosenescence. Springer, Champ

Authors : Compté N, Pepersack T, Goriely S
Year : 2018
Journal : Book
Volume : -
Pages : 1-18

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?

Authors : Lambertini M, Viglietti G, de Azambuja E
Year : 2018
Journal : ESMO Open
Volume : 3
Pages : e000350

Risk factors for the development of brain metastases in patients with HER2-positive breast cancer.

Authors : Maurer C, Tulpin L, Moreau M, Dumitrescu C, de Azambuja E, Paesmans M, Nogaret JM, Piccart-Gebhart M, Awada A
Year : 2018
Journal : ESMO Open
Volume : 3
Pages : e000440

Early postsurgical temozolomide treatment in newly diagnosed bad prognosis glioblastoma patients: Feasibility study.

Authors : Chaskis E, Luce S, Goldman S, Sadeghi N, Melot C, De Witte O, Devriendt D, Lefranc F
Year : 2018
Journal : Bull Cancer
Volume : 105
Pages : 664-670

Network science in clinical trials: A patient-centered approach.

Authors : Manem VSK, Salgado R, Aftimos P, Sotiriou C, Haibe-Kains B
Year : 2018
Journal : Semin Cancer Biol
Volume : 52
Pages : 135-150

Calcitonin and Carcinoembryonic Antigen for the Diagnosis and Management of Medullary Thyroid Carcinoma. in : Luca Giovanella, Editor. Atlas of Thyroid and Neuroendocrine Tumor Markers. Springer

Authors : Costante G, Lalami Y, Jungels C, Awada A
Year : 2018
Journal : Book
Volume : -
Pages : 133-150

Celyad's novel CAR T-cell therapy for solid malignancies.

Authors : Lonez C, Hendlisz A, Shaza L, Aftimos P, Vouche M, Donckier V, Machiels JH, Van den Eynde M, Canon JL, Carrasco J, Odunsi K, Sahebjam S, Rottey S, Braun N, Verma B, Gilham DE, Lehmann FF
Year : 2018
Journal : Curr Res Transl Med
Volume : 66(2)
Pages : 53-56

Development of the Multi-Dimensional Analysis of Patient Outcome Predictions (MD.POP) during medical encounters.

Authors : Ménard C, Libert Y, Canivet D, Van Achte L, Farvacques C, Liénard A, Merckaert I, Reynaert C, Slachmuylder JL, Durieux JF, Klastersky J, Razavi D
Year : 2018
Journal : Patient Educ Couns
Volume : 101(1)
Pages : 52-58

Cancer immunotherapy-associated hypophysitis.

Authors : Solinas C, Porcu M, De Silva P, Musi M, Aspeslagh S, Scartozzi M, Willard-Gallo K, Mariotti S, Saba L
Year : 2018
Journal : Semin Oncol
Volume : 45
Pages : 181-186

Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis.

Authors : Poggio F, Bruzzone M, Ceppi M, Conte B, Martel S, Maurer C, Tagliamento M, Viglietti G, Del Mastro L, de Azambuja E, Lambertini M
Year : 2018
Journal : ESMO Open
Volume : 3
Pages : e000361

Choice of chemotherapy regimen for early HER2-positive breast cancer in elderly patients.

Authors : Pondé N, de Azambuja E
Year : 2018
Journal : Chin Clin Oncol
Volume : 7(1)
Pages : 4